The CagriSema study results are a setback for the Danish drugmaker in its efforts to regain ground lost to Eli Lilly in the obesity-drug market.
Source link
Novo Nordisk Shares Plunge After Obesity Drug Fails to Beat Zepbound
Date:
More like thisRelated
Perez passes Brett with 318 homers as a Kansas City Royal
Jul 25, 2026, 03:31 PM ETDETROIT -- Salvador Perez...
Trump conditions a landmark nuclear agreement, and a unique critter goes viral: The news quiz
Ukraine makes a big wartime shake-up after protests, an...
Heat dome expands across central US, causing dangerous conditions
Heat dome expands across the central United States, creating...
Will Staten + Quinn Marry on ‘Ransom Canyon’?
Staten Kirkland and Quinn O'Grady have become a beloved...